Search Orphan Drug Designations and Approvals
-
| Generic Name: | ex-vivo cultered adult human mesenchymal stem cells |
|---|---|
| Date Designated: | 04/30/2010 |
| Orphan Designation: | Treatment of Type 1 diabetes patients with residual beta cell function |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Mesoblast, Inc. 505 Fifth Avenue Third Floor New York, New York 10017 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







